Cantel Medical (NYSE:CMD) Upgraded to Buy by ValuEngine

ValuEngine upgraded shares of Cantel Medical (NYSE:CMD) from a hold rating to a buy rating in a research note published on Wednesday morning, ValuEngine reports.

CMD stock traded up $0.30 during trading hours on Wednesday, hitting $61.18. 7,104 shares of the stock traded hands, compared to its average volume of 321,494. The stock has a 50-day simple moving average of $71.53 and a 200 day simple moving average of $77.79. Cantel Medical has a one year low of $60.22 and a one year high of $93.87. The company has a market cap of $2.63 billion, a P/E ratio of 25.81 and a beta of 0.96. The company has a current ratio of 2.45, a quick ratio of 1.36 and a debt-to-equity ratio of 1.26.

Cantel Medical (NYSE:CMD) last issued its quarterly earnings results on Tuesday, December 10th. The company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.57 by $0.08. Cantel Medical had a net margin of 4.38% and a return on equity of 14.91%. The firm had revenue of $257.25 million for the quarter, compared to analysts’ expectations of $250.70 million. Analysts forecast that Cantel Medical will post 2.8 earnings per share for the current year.

The firm also recently disclosed a Semi-Annual dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, January 17th will be paid a $0.105 dividend. The ex-dividend date is Thursday, January 16th. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.10. Cantel Medical’s payout ratio is currently 8.44%.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

See Also: New Google Finance Tool and Screening Stocks

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.